CVS Health: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Nov. 4, 2026, CVS Health (NYSE:CVS) announced its plan to separate into two independent publicly traded companies. The corporate separation lets the business tailor its capital allocation while giving each stand-alone business a sharper operating focus. Three things management said stand out.

1. Corporate Separation Unlocks Focused Capital Allocation

Management is separating the enterprise into two publicly traded businesses to sharpen operational focus. CVS Health will retain its Aetna health insurance unit and Caremark pharmacy benefit manager, while CVS Pharmacy will operate the national retail store network.

Today, announced our intention to separate into 2 independent publicly traded companies. This decision marks the next important chapter in the evolution of CVS Health. We are creating 2 distinct leaders in healthcare,
-- J. David Joyner CEBS, Chairman and Chief Executive Officer

2. Balance Sheet Strength Triggers Share Buyback Resumption

Management reached its target leverage ahead of schedule, following $15.3 billion in year-to-date operating cash flow. That balance sheet progress gives the company room to restart buying back its own stock in the fourth quarter.

Our execution has significantly strengthened our balance sheet allowing us to achieve target leverage ahead of schedule and will enable us to resume our share repurchase program in the fourth quarter.
-- Brian O. Newman, Chief Financial Officer

3. Medicare Advantage Repricing Drives Health Benefits Margin Recovery

The Aetna health insurance segment improved profitability through disciplined pricing and medical cost management across its Medicare Advantage business, which provides private Medicare plans for seniors. Those operational adjustments helped offset industrywide medical cost pressures.

Performance in our Medicare book modestly exceeded our expectations driven by pockets of favorability as a result of strong medical cost management and disciplined pricing.
-- Brian O. Newman, Chief Financial Officer

Looking Ahead

Execution across medical and pharmacy segments is accelerating earnings, and leadership isn't hiding its satisfaction about it. Integrated health assets provide structural advantages while leadership monitors pricing discipline across benefits.

We now believe we will be in the high end of our mid-teens adjusted EPS CAGR through 2028.
-- Brian O. Newman, Chief Financial Officer

The planned separation aims to position both stand-alone units to adapt quickly while building long-term value.

By taking this deliberate action, we are creating simpler, stronger, and more focused companies.
-- J. David Joyner CEBS, Chairman and Chief Executive Officer

The Motley Fool recommends CVS Health. The Motley Fool has a disclosure policy.